Medindia

X

FDA Approves New HIV Drug

by Sheela Philomena on  May 21, 2011 at 9:06 AM Drug News   - G J E 4
The US Food and Drug Administration approved a new HIV drug, Edurant. This medication fights HIV in combination with other antiretrovirals.
 FDA Approves New HIV Drug
FDA Approves New HIV Drug
Advertisement

Made by the New Jersey based Tibotec Therapeutics, Edurant helps block the virus from replicating and is part of a class of drugs known as non-nucleoside reverse transcriptase inhibitor.

Advertisement
The pill is to be taken once daily with food, the FDA said.

"Patients may respond differently to various HIV drugs or experience varied side effects," said Edward Cox, director of the office of antimicrobial products in the FDA's Center for Drug Evaluation and Research.

"FDA's approval of Edurant provides an additional treatment option for patients who are starting HIV therapy."

The approval followed phase II and II trials that showed that patients who had not received previous therapy saw an 83 percent lower viral load after they took Edurant along with other antiretroviral drugs.

Side effects included depression, insomnia, headache and rash.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All